Tarsus Pharmaceuticals (TARS) Shares Issued (2020 - 2025)
Historic Shares Issued for Tarsus Pharmaceuticals (TARS) over the last 6 years, with Q2 2025 value amounting to -$354000.0.
- Tarsus Pharmaceuticals' Shares Issued fell 2919.71% to -$354000.0 in Q2 2025 from the same period last year, while for Sep 2025 it was $45.8 million, marking a year-over-year increase of 4376571.43%. This contributed to the annual value of $9.4 million for FY2024, which is 85076.14% up from last year.
- Per Tarsus Pharmaceuticals' latest filing, its Shares Issued stood at -$354000.0 for Q2 2025, which was down 2919.71% from $135.1 million recorded in Q1 2025.
- Over the past 5 years, Tarsus Pharmaceuticals' Shares Issued peaked at $135.1 million during Q1 2025, and registered a low of -$98.4 million during Q4 2023.
- In the last 5 years, Tarsus Pharmaceuticals' Shares Issued had a median value of -$3000.0 in 2021 and averaged $9.1 million.
- Its Shares Issued has fluctuated over the past 5 years, first plummeted by 3353438.91% in 2022, then surged by 75839230.77% in 2024.
- Tarsus Pharmaceuticals' Shares Issued (Quarter) stood at $221000.0 in 2021, then plummeted by 33534.39% to -$73.9 million in 2022, then crashed by 33.16% to -$98.4 million in 2023, then rose by 9.62% to -$88.9 million in 2024, then skyrocketed by 99.6% to -$354000.0 in 2025.
- Its Shares Issued stands at -$354000.0 for Q2 2025, versus $135.1 million for Q1 2025 and -$88.9 million for Q4 2024.